Cholera Vaccines Market Size Worth USD 1.25 Billion By 2024: Grand View Research, Inc.
Global cholera vaccines market is expected to reach over
USD 1.25 billion by 2024, according to a new report by Grand View Research,
Inc. The presence of wide range of promising vaccine candidates in the pipeline
is anticipated to accentuate growth of the cholera vaccines market over the
forecast period. In July 2016, Valneva SE has announced completion of phase II
clinical trial for Clostridium difficile vaccine candidate.
Moreover, a large number of government organizations working
toward spreading awareness about immunization against the fatal diseases, such
as cholera, are expected to boost the market growth. For instance, UNICEF is
involved in provision of funding for the cholera immunization initiatives taken
up by the governments of highly cholera prominent countries, such as Kenya and
Iraq.
Browse full research report on Cholera Vaccines Market:
http://www.grandviewresearch.com/industry-analysis/cholera-vaccines-market
Further Key Findings from the Study Suggest:
- Dukoral
was the first oral cholera vaccine to get approval in the European Union
during the year 2004. This is a drinkable dosage form, which is
recommended especially for travelers. Immunization requires 2 doses of the
formulation that provides up to 3 months of protection against the target
disease.
- Shanchol
was the first vaccine that was licensed and developed with support from
Gates Foundation. This molecule was produced by Shantha Biotechnics and
made available in India during 2009.
- Vaxchora
is the recently (i.e., 2016) launched single dose, live attenuated
formulation that is the only approved cholera vaccine in the U.S. This
product segment is expected to reach over USD 290 million till 2024.
- Europe
dominated the market in terms of revenue with over USD 203.27 million in
2015mainly due to the availability of approved cholera vaccines such as
Dukoral and Shanchol coupled with extensive research and development
activities and the existence of key participants of the industry in this
region
- Introduction
of first cholera vaccine during 2016 in the U.S. is expected to be the
major factor for the boost in growth of North American cholera market with
a fastest CAGR of over 12% during the forecast period.
- Asia
Pacific region is expected to follow this high market growth with a CAGR
of over 10% from 2016 to 2024 attributable to the growing target
population base with high unmet clinical needs.
- Moreover,
government support in the Asia Pacific region is expected to drive the
market growth. Major regulatory authorities for regulation of immunization
in Asia Pacific include State Food and Drug Administration, Pharmaceutical
and Medical Safety Bureau, Drugs Controller General of India, etc. These
authorities maintain easy availability of safe and cost-effective cholera
vaccines in this region, due to high frequency of epidemics.
- Some
leading players in this market are, Valneva, PaxVax, and Shantha
Biotechnics Limited. New entrants in the market, such as Valneva and
Celldex Therapeutics, Inc. are involved in the research and development of
promising target disease immunization molecules.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global cholera
vaccines market on the basis of product and region:
Global Cholera Vaccines Market by Product (Revenue, USD
Million, 2013 - 2024)
- Dukoral
- Shanchol
- Vaxchora
- Others
Cholera Vaccines Market by Region (Revenue, USD
Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- India
- China
- Latin
America
- Brazil
- MEA
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-cholera-vaccines-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment